Dusseldorf - Dusseldorf Delayed Price. Currency in EUR
-1.46 (-1.87%)
At close: 7:50PM CET
Stock chart is not supported by your current browser
Previous Close78.23
Bid0.00 x 0
Ask0.00 x 0
Day's Range76.77 - 77.58
52 Week Range38.47 - 81.11
Avg. Volume5
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Reuters

    FMC sees U.S. government easing home dialysis goals

    Fresenius Medical Care (FMC) , the world's largest kidney dialysis provider, is confident the U.S. government will soften initial targets for treating patients with kidney disease at home rather than in dedicated centres. Chief Executive Rice Powell told Reuters a goal laid out by the U.S. Department of Health and Human Services (HHS) last July for 80% of new patients to undergo dialysis at home or receive organ transplants by 2025 was under review amid industry criticism. While Fresenius is developing less bulky and easier-to-use dialysis equipment and smartphone apps for home treatment, Powell said dialysis companies risked financial penalties if they kept patients who were deemed unsuitable for home treatment in dialysis centres under the new goals.

  • DaVita Names Kenny Gardner Chief People Officer
    PR Newswire

    DaVita Names Kenny Gardner Chief People Officer

    DaVita Kidney Care recently announced Kenny Gardner as its new chief people officer (CPO). Gardner has been with DaVita for nearly a decade and most recently served the company as a group vice president (GVP), overseeing field operations in the Southeast U.S.


    Wall Street Posts Gains on Tuesday

    Hasbro tumbles on fourth-quarter results Continue reading...

  • First Eagle Buys Buffett's DaVita in the 4th Quarter

    First Eagle Buys Buffett's DaVita in the 4th Quarter

    Firm of GuruFocus Value Conference Keynote Speaker releases portfolio Continue reading...

  • DaVita shares how federal and state policies are already shaping its 2020
    American City Business Journals

    DaVita shares how federal and state policies are already shaping its 2020

    The company continues to focus on state policy, but will not pursue its own ballot initiative in California.

  • DaVita Inc. 4th Quarter 2019 Results
    PR Newswire

    DaVita Inc. 4th Quarter 2019 Results

    DaVita Inc. (NYSE: DVA) today announced results for the quarter and year ended December 31, 2019.

  • At US$81.34, Is DaVita Inc. (NYSE:DVA) Worth Looking At Closely?
    Simply Wall St.

    At US$81.34, Is DaVita Inc. (NYSE:DVA) Worth Looking At Closely?

    Today we're going to take a look at the well-established DaVita Inc. (NYSE:DVA). The company's stock saw a significant...

  • 10 of the Cheapest Warren Buffett Stocks

    10 of the Cheapest Warren Buffett Stocks

    Warren Buffett, chairman and CEO of legendary holding company Berkshire Hathaway (BRK.B), is often called the greatest value investor of all time. Although Buffett identifies targets based on their "intrinsic value," a number of Berkshire's holdings look like cheap stocks by more prosaic value indicators, too.Not every stock held by Berkshire Hathaway is necessarily a bargain at its current share price. After all, Buffett has held some of these names for decades. To that end, we scoured Berkshire Hathaway's portfolio of nearly 50 stocks to find the ones that look like they're on sale these days.In some cases, we relied on forward price-to-earnings multiples, which show what a stock costs in light of its expected earnings growth. (The S&P; 500, by the way, trades at 18.6 times expected earnings, by Yardeni Research's calculations.) In others, we also took into consideration book values. And naturally we paid attention to long-term growth forecasts and fundamentals.After sorting through the Berkshire Hathaway equity portfolio with those criteria in mind, these 10 names stood out among the cheapest Warren Buffett stocks. SEE ALSO: Every Warren Buffett Stock Ranked: The Berkshire Hathaway Portfolio

  • Kidney-care startup from former DaVita execs looks to fill gaps in care
    American City Business Journals

    Kidney-care startup from former DaVita execs looks to fill gaps in care

    A new kidney-care organization founded by former DaVita executives is looking to use predictive analytics to catch kidney disease in patients earlier. Strive Health, launched in Denver in 2018, has now secured a key partnership with SSM Health, a health system. Strive is the brainchild of former DaVita Inc. (NYSE: DVA) executives Bob Badal and Chris Riopelle.

  • DaVita Celebrates 2019 Achievements
    PR Newswire

    DaVita Celebrates 2019 Achievements

    DaVita is closing the decade by highlighting its milestones and achievements from 2019.

  • 5 Health Care Stocks Gurus Are Buying

    5 Health Care Stocks Gurus Are Buying

    DaVita on the list Continue reading...

  • Do You Like DaVita Inc. (NYSE:DVA) At This P/E Ratio?
    Simply Wall St.

    Do You Like DaVita Inc. (NYSE:DVA) At This P/E Ratio?

    This article is for investors who would like to improve their understanding of price to earnings ratios (P/E ratios...

  • Hedge Fund Favorites vs. DaVita Inc (DVA) In 2019
    Insider Monkey

    Hedge Fund Favorites vs. DaVita Inc (DVA) In 2019

    Hedge funds are known to underperform the bull markets but that's not because they are bad at investing. Truth be told, most hedge fund managers and other smaller players within this industry are very smart and skilled investors. Of course, they may also make wrong bets in some instances, but no one knows what the […]

  • Is There An Opportunity With DaVita Inc.'s (NYSE:DVA) 29% Undervaluation?
    Simply Wall St.

    Is There An Opportunity With DaVita Inc.'s (NYSE:DVA) 29% Undervaluation?

    Today we will run through one way of estimating the intrinsic value of DaVita Inc. (NYSE:DVA) by estimating the...

  • Here is What Hedge Funds Think About DaVita Inc (DVA)
    Insider Monkey

    Here is What Hedge Funds Think About DaVita Inc (DVA)

    Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through the end of November. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 54% and 51% respectively. Our research shows that most of the stocks that smart money likes historically generate strong […]

  • RTD's staffing woes aren't just a commuter headache; Denver business is worried, too
    American City Business Journals

    RTD's staffing woes aren't just a commuter headache; Denver business is worried, too

    Burdened by a shortage of drivers due to an operator turnover rate that is hovering around 100% over the past 33 months, the transit agency is exploring potential “temporary” cutbacks that it hopes will slow the hemorrhage of drivers now required to work six days a week and, in doing so, stop the last-minute cancellations of routes that have created, in the words of one rider, the “RTD roulette” that passengers now must play. RTD General Manager David Genova — who abruptly announced his resignation on Nov. 22, effective in early 2020 — said any reductions in service won’t go into play until March at the earliest or possibly May. As he and other RTD leaders are looking for cuts, they will lean heavily toward reductions in frequencies of trains and buses rather than eliminations of lines.

  • 7 Sickly Healthcare Stocks to Avoid

    7 Sickly Healthcare Stocks to Avoid

    If we can be sure of one thing in 2019, it's that not all stocks are created equal.We have seen sectors rise and some of the big names falter all the same. This has certainly been a stock picker's market.And I say that knowing full well that the S&P 500 is up an impressive 26% year-to-date.InvestorPlace - Stock Market News, Stock Advice & Trading TipsBut healthcare is a tricky sector because it incorporates a variety of stocks -- from drug companies to hospitals to insurers to medical device makers. All are on different sales calendars and don't march in lockstep.The thing to watch in the sector is how the economy is doing. If people are working then they have more money, and they will use some of that money for healthcare purposes.As far as legislation that can clear up the direction of the U.S. healthcare system, that is a long way away. * 7 Marijuana Penny Stocks That Have Ridiculous Possibilities For now, it's best to stick with only the most powerful stocks the market has to offer -- and avoid the weakest. And the doctor is ordering you to banish these seven sickly healthcare stocks from your portfolio, if you've got them. Healthcare Stocks to Sell: Mednax (MD)Source: IgorGolovniov / Mednax (NYSE:MD) is a Florida-based firm that has been supplying physician services for anesthesia, pediatric specialties and newborns since 1976.These contract services have been in big demand for a while, as the healthcare landscape was developing under new "Obamacare" legislation.But those days are passed and healthcare organizations are settling in the current state of limbo. But that means staffing is a bit more predictable and MD's services are finding fewer customers.MD has begun restructuring to get back in step with market conditions. Whether that works or not, remains to be seen. But it's getting downgraded across the board and year-over-year revenue is declining. There's more downside than upside left for this stock. Fresenius Medical Care (FMS)Source: OleksandrShnuryk / Fresenius Medical Care (NYSE:FMS) has been doing pretty well this year, relative to the category it finds itself in today.This Germany-based firm specializes in treatment and services for patients with chronic kidney failure and is one of the top providers, along with DaVita (NYSE:DVA). The problem is, while this is a growth sector, especially in the United States, Medicare is tight with its payments, so the margins are low. And solid operating margins are crucial to the profitability standards I set for any investment.In July, President Donald Trump issued an executive order allowing in-home services for kidney dialysis and other treatments and both sector-leading stocks popped.But it may not be FMS that is the biggest winner, especially given the fact that its dialysis clinics and home services would initially add to costs. This is ultimately a win for insurers rather than these specialized companies. * 7 Killer Stocks No One Knows About The stock is only down 3% in the past year, but it's up 13% year-to-date, so this performance is showing a downtrend is still in place. Healthcare Services Group (HCSG)Source: Shutterstock Healthcare Services Group (NASDAQ:HCSG) is a good example of a middling company in the ancillary services sector of the healthcare industry -- including laundry and dietary services for long-term care facilities -- that has been struggling between strength and weakness for a while.It's a good sector and it is a pretty big name in the industry, having been around since 1976. But the dynamics in this sector are shifting, as the insurance industry would prefer to pay to keep people at home, rather than pay for facilities. The same goes for Medicare.Struggles with margins have been ongoing. And then in late October, third-quarter earnings hammered the company. While revenue was in line with expectations, earnings missed by almost 10%. That's not encouraging.It also means analysts cut their price targets moving forward and institutional investors are looking to move their money, further driving down the stock. Brookdale Senior Living (BKD)Source: Pavel Kapysh / Brookdale Senior Living (NYSE:BKD) provides senior living communities to more than 75,000 residents. It has been in business since 2005.During that time, BKD has been able to capture the first wave of baby boomers and the tail end of their parents heading into assisted living facilities. And this market looked like it was going to expand for decades as boomers started filling up these facilities in huge numbers.Now, real estate is an area I'd consider crucial to my Growth Investor strategy … if the business model is strong. But along the way, technology has shifted this particular trend. In-home care has increased and there is now more care that can be conducted from homes due to advances in equipment.This means assisted living facilities are under pressure. They proliferated, anticipating a growing base, and now that growth looks to be less than expected. Given the fact that they've dumped huge sums in large campuses, this is not the "sure thing" it was five years ago. * 9 Tantalizing Dividend Stocks for 2020 There will be growing competition in this sector and Medicare and insurers will have some leverage here, all challenging BKD's margins in coming quarters, if not years. HCA Healthcare (HCA)Source: Trismegist san / HCA Healthcare (NYSE:HCA) is a for-profit company that operates hospitals, urgent care facilities, outpatient services facilities and the like.It was founded in 1968 and comprises nearly 250,000 employees in 21 states, including 38,000 physicians and 87,000 nurses. It's No. 63 in the Fortune 500.This isn't a stock or company teetering on the brink of existence. But it will be in an increasingly challenging sector moving forward.The graying of America was supposed to be a boon for these types of companies. But the real challenge underneath it all is how Americans pay for all of this increased healthcare.Insurance companies are not interested in expanding the margins for hospital companies. And Medicare is already under pressure for funding as it is; more people in the system won't help its generosity.This is one of those stocks that may not fall significantly, but it won't rise much either. There are simply better places to put your money to work. Cigna (CI)Source: Piotr Swat / Cigna (NYSE:CI) is one of the leading health insurers in the U.S. and beyond. It has a $75 billion market capitalization and has been around since 1792. Nope, that not a typo, it's 227 years old.It bought the first insurer in America -- Insurance Company of North America -- in a 1982 merger. That's some serious staying power.Recently, this sector has been under duress because Wall Street was worried that Democratic presidential candidate Elizabeth Warren was going to destroy the health insurance industry with her Medicare for All health coverage program.But Warren recently laid out the plan and it looks like such an outcome would be at least three years out if she were to be elected. And that means it would be up for implementation as she ran for a second term, which gives companies even more time. * 10 Cheap Stocks to Buy Under $10 CI and other insurers were all part of a relief rally. But the fact is, the popularity of Medicare for All isn't lost on these big insurers. And it's going to be a tough transition to come up with a better private solution or figure out what to do when the current system transitions. In the meantime, I see much stronger stocks out there. Encompass Health (EHC)Source: Piotr Swat / Encompass Health (NYSE:EHC) provides post-acute healthcare services, such as inpatient and in-home rehabilitation as well as hospice care.Basically, it's part of a growth sector that benefits from the graying U.S. population as well as the trend to provide services outside brick-and-mortar corporate facilities.And its home care services are broader than simply rehabilitation. It provides nursing care as well as physical therapy. Also, its physical therapy division is available to people of all ages that are in need of rehabilitation services.The trouble is, this sector is in its early days and the industry is undergoing some volatility, given the vague future of U.S. healthcare policy, and thus, how companies can best adapt.Plus, the enthusiasm for this sector a few years ago has made stocks like EHC relatively expensive, so its valuations aren't in line with the current state of the sector. Wall Street doesn't like surprises, and this sector may be full of them in coming quarters.There are certainly worse stocks out there, but there are also better ones right now. Why I Like Dividend Growth Stocks NowIf you think what happened in the stock market the last few months is wild, just look at the bond market. We've got falling and even negative yields overseas. But as investors retreat to U.S. Treasuries it's causing bizarre effects here, too. Just look at what happened this summer, when the two-year Treasury actually began to yield MORE than the 10-year Treasury. And even the 30-year Treasury can't be relied upon for good yield anymore.So if a stock's earnings picture is uncertain, not only is it going to be volatile, but people are going to look elsewhere seeking income.Meanwhile, other stocks not only earn an "A" in my Portfolio Grader, thanks to strong buying pressure and great fundamentals …The stocks also earn an "A" in my Dividend Grader. These stocks are able to pay great yields -- and have the strong business model to back it up.All in all, I've got 29 strong dividend growth stocks for you now in Growth Investor -- averaging 4% yields -- far more than the S&P 500 or even a Treasury bond. These stocks are poised to do well as we continue to see international capital flow to the U.S. markets. Click here to see how I found these stocks, and how you can get great performance out of YOUR portfolio -- come what may.Louis Navellier had an unconventional start, as a grad student who accidentally built a market-beating stock system -- with returns rivaling even Warren Buffett. In his latest feat, Louis discovered the "Master Key" to profiting from the biggest tech revolution of this (or any) generation. Louis Navellier may hold some of the aforementioned securities in one or more of his newsletters. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Marijuana Penny Stocks That Have Ridiculous Possibilities * 7 High-Yield ETFs to Buy Now * 4 Dow Jones Industrial Average Stocks to Sell The post 7 Sickly Healthcare Stocks to Avoid appeared first on InvestorPlace.

  • Can You Imagine How DaVita's (NYSE:DVA) Shareholders Feel About The 15% Share Price Increase?
    Simply Wall St.

    Can You Imagine How DaVita's (NYSE:DVA) Shareholders Feel About The 15% Share Price Increase?

    Low-cost index funds make it easy to achieve average market returns. But across the board there are plenty of stocks...

  • For DaVita subsidiary Vively, it's not just about dialysis care
    Yahoo Finance

    For DaVita subsidiary Vively, it's not just about dialysis care

    DaVita renamed its health solutions subsidiary to boost its efforts outside kidney care.


    US Stocks Retreat Wednesday

    CVS Health posts 3rd-quarter earnings beat Continue reading...

  • DaVita warns of potential California ballot battle redux in 2020
    American City Business Journals

    DaVita warns of potential California ballot battle redux in 2020

    On its Q3 earnings call with investors, DaVita shared that it was factoring in the costs of opposing the initiative, which it spent record dollars to do in 2018.

  • Cerner signs 5-year deal with newly rebranded DaVita division
    American City Business Journals

    Cerner signs 5-year deal with newly rebranded DaVita division

    As part of a five-year agreement, Vively Health will adopt Cerner's electronic health record system, population health management platform and consumer software.

  • Former P&G manager to join C-suite of global health care firm
    American City Business Journals

    Former P&G manager to join C-suite of global health care firm

    Former Procter & Gamble Co. manager John Winstel has been hired to serve as the next chief accounting officer of DaVita Inc., a global Fortune 500 company that is the largest provider of kidney care services in the United States.

  • DaVita Health Solutions rebrands as Vively Health, partners with Cerner
    American City Business Journals

    DaVita Health Solutions rebrands as Vively Health, partners with Cerner

    DaVita Health Solutions is being rebranded as Vively Health. Vively will continue to be DaVita’s branch for providing in-home primary care for high-risk, chronically ill patients. DaVita Health Solutions was formed in 2017 by its parent company as a way to help care for the most clinically complex patients in the U.S. DaVita Inc. (NYSE: DVA), the Denver-based kidney care health provider, has been focusing on more at-home health care, CEO Javier Rodriguez shared in an interview with Denver Business Journal.

  • American City Business Journals

    See where the 25 highest-paid Colorado CEOs went to college (Photos)

    Some of the highest-earning CEOs of Colorado public companies hold degrees from Ivy League schools. But they're far from the norm.